Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.

Diagnostic tools in Rhinology EAACI position paper. Clin Transl Allergy (2011) 1.27

Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res (2010) 1.19

Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India (2015) 1.07

Clinical features and diagnosis of aspirin induced asthma. Thorax (2000) 0.94

Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry. Thorax (2000) 0.85

Clinical Management of Nonsteroidal Anti-inflammatory Drug Hypersensitivity. World Allergy Organ J (2008) 0.81

Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice? Allergy Asthma Immunol Res (2015) 0.79

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease: asthma and rhinitis. Clin Exp Allergy (2013) 0.79

An evaluation of short-term corticosteroid response in perennial allergic rhinitis using histamine and adenosine monophosphate nasal challenge. Br J Clin Pharmacol (2003) 0.78

Aspirin-sensitive asthma and upper airway diseases. Am J Rhinol Allergy (2012) 0.78

Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad. Eur Arch Otorhinolaryngol (2012) 0.78

Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis. Curr Allergy Asthma Rep (2015) 0.75

Galectin-10 is released in the nasal lavage fluid of patients with aspirin-sensitive respiratory disease. ScientificWorldJournal (2012) 0.75

Low prevalence of hypersensitivity to nonsteroidal anti-inflammatory drugs in Chinese patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol (2014) 0.75

Aspirin-exacerbated respiratory disease and current treatment modalities. Eur Arch Otorhinolaryngol (2016) 0.75

Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (2013) 2.35

Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J (1975) 2.29

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest (1998) 2.13

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J (2000) 2.00

Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol (1977) 1.88

Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax (2004) 1.80

Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy (2001) 1.67

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61

Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost (2006) 1.61

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet (1979) 1.57

Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood (2001) 1.54

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53

Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax (2007) 1.48

Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet (1997) 1.43

Inhibition of thrombin generation by aspirin. Thromb Haemost (1994) 1.40

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30

Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J (2000) 1.29

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol (2001) 1.25

Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. J Allergy Clin Immunol (1976) 1.25

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med (1998) 1.24

Asthma relieved by aspirin and by other cyclo-oxygenase inhibitors. Thorax (1978) 1.24

Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol (2000) 1.22

Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J (2000) 1.13

Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol (2001) 1.13

Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J (1993) 1.13

The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol (1987) 1.12

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy (2003) 1.11

Haemodynamic changes induced by prostacyclin in man. Br Heart J (1980) 1.11

Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost (2006) 1.10

Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med (1996) 1.09

Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy (2009) 1.08

Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med (1994) 1.05

Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med (1995) 1.05

Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01

The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (1996) 1.00

Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy (1997) 1.00

Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation (2001) 1.00

Bronchodilatory properties of 2-decarboxy-2-hydroxymethyl prostaglandin E1. Prostaglandins (1985) 0.98

Prostacyclin for pulmonary hypertension. Lancet (1980) 0.98

Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thromb Res (1999) 0.96

Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart (2000) 0.96

Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int Arch Allergy Immunol (1997) 0.94

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol Res Commun (1978) 0.94

Clinical features and diagnosis of aspirin induced asthma. Thorax (2000) 0.94

Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. N Engl J Med (2001) 0.93

Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost (1985) 0.92

Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med (1996) 0.92

Value of transthoracic echocardiography for the detection of high-grade coronary artery stenosis: prospective evaluation in 50 consecutive patients scheduled for coronary angiography. J Am Soc Echocardiogr (2000) 0.92

Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2000) 0.92

Cardiopulmonary function in 1 -antitrypsin heterozygotes exposed to severe air pollution. Am Rev Respir Dis (1973) 0.92

Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. Prostaglandins (1986) 0.90

Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis (2002) 0.90

Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol (1997) 0.90

Heterogeneity of serum gamma-glutamyl transpeptidase in hepatobiliary diseases. Clin Chim Acta (1967) 0.90

Adverse reactions to suxamethonium and other muscle relaxants under general anesthesia. J Allergy Clin Immunol (1983) 0.90

A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma. Clin Exp Allergy (2000) 0.89

Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet (1999) 0.89

Serum peptidases in myocardial infarction. Br Heart J (1972) 0.88

Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy (2009) 0.88

Cyclosporin for steroid-dependent asthma. Allergy (1991) 0.87

Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J (2003) 0.86

Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery (1980) 0.86

Immunological status of patients with recurrent chest infections. Lung (1978) 0.86

The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels. Allergy (2006) 0.86

Anti-platelet action of intravenous infusion of prostacyclin in man. Thromb Res (1978) 0.86

Myocardial infarction in status asthmaticus. Lancet (1977) 0.86

Altered distribution of IgG subclasses in aspirin-induced asthma: high IgG4, low IgG1. Clin Exp Allergy (1992) 0.85

Blood fibrinolytic activity, social class and habitual physical activity--II. A study of black and white men in Southern Georgia. J Chronic Dis (1980) 0.85

Thromboxane generation and platelet aggregation in survivals of myocardial infarction. Thromb Haemost (1978) 0.85

[Liver cirrhosis and dysimmunoglobulinemia in a patient with Pi M phenotype alpha 1-antitrypsin deficiency]. Pol Arch Med Wewn (1977) 0.85

Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. J Physiol Pharmacol (2007) 0.84

Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb Haemost (1986) 0.84

Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Prostaglandins (1981) 0.84

Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns. Drugs (1983) 0.84

Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy (2004) 0.84

Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. Pharmacol Res Commun (1977) 0.84

Impaired response of the forearm resistance but not conductance vessels to reactive hyperemia in hypertrophic cardiomyopathy. Angiology (1999) 0.84

Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart Vessels (1996) 0.84

Inhibition of prostacyclin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis. Mater Med Pol (1979) 0.83

Prostacyclin for acute coronary insufficiency. Artery (1980) 0.83

Trypsin-like activity of serum: its origin and electrophoretic separation. Clin Chim Acta (1969) 0.83

Cytokine production in human and rat macrophages and dicatechol rooperol and esters. Biochem Pharmacol (1996) 0.82